These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7102261)

  • 1. Prognosis of multiple sclerosis. Results from an epidemiological area in Germany.
    Poser S; Bauer HJ; Poser W
    Acta Neurol Scand; 1982 Apr; 65(4):347-54. PubMed ID: 7102261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-antigens and the prognosis of multiple sclerosis.
    Poser S; Ritter G; Bauer HJ; Grosse-Wilde H; Kuwert EK; Raun NE
    J Neurol; 1981; 225(3):219-21. PubMed ID: 6167687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological investigations into multiple sclerosis in Southern Hesse. V. Course and prognosis.
    Lauer K; Firnhaber W
    Acta Neurol Scand; 1987 Jul; 76(1):12-7. PubMed ID: 3498287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and disability progression in multiple sclerosis in Tunisia: do we really have a more aggressive disease course?
    Sidhom Y; Damak M; Riahi A; Hizem Y; Mrissa R; Mhiri C; Gouider R
    J Neurol Sci; 2014 Aug; 343(1-2):110-4. PubMed ID: 24980939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
    Martinez-Lapiscina EH; Arnow S; Wilson JA; Saidha S; Preiningerova JL; Oberwahrenbrock T; Brandt AU; Pablo LE; Guerrieri S; Gonzalez I; Outteryck O; Mueller AK; Albrecht P; Chan W; Lukas S; Balk LJ; Fraser C; Frederiksen JL; Resto J; Frohman T; Cordano C; Zubizarreta I; Andorra M; Sanchez-Dalmau B; Saiz A; Bermel R; Klistorner A; Petzold A; Schippling S; Costello F; Aktas O; Vermersch P; Oreja-Guevara C; Comi G; Leocani L; Garcia-Martin E; Paul F; Havrdova E; Frohman E; Balcer LJ; Green AJ; Calabresi PA; Villoslada P;
    Lancet Neurol; 2016 May; 15(6):574-84. PubMed ID: 27011339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis.
    Phadke JG
    Brain; 1990 Dec; 113 ( Pt 6)():1597-628. PubMed ID: 2276037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study.
    Minderhoud JM; van der Hoeven JH; Prange AJ
    Acta Neurol Scand; 1988 Jul; 78(1):10-5. PubMed ID: 3176876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression index and disability status in multiple sclerosis: a resurvey of 207 patients in central Poland.
    Cendrowski WS
    Schweiz Arch Neurol Psychiatr (1985); 1986; 137(4):5-13. PubMed ID: 2428106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of benign multiple sclerosis: Clinical and HLA correlates in a Western Australian cohort.
    Fabis-Pedrini MJ; James I; Seewann A; Yau WY; van de Bovenkamp AA; Sanders FRK; Qiu W; Burton J; Mastaglia FL; Carroll WM; Kermode AG
    J Neurol Sci; 2018 May; 388():12-18. PubMed ID: 29627005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and long term prognosis in early onset multiple sclerosis.
    Deryck O; Ketelaer P; Dubois B
    J Neurol; 2006 Jun; 253(6):720-3. PubMed ID: 16502213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rehabilitation for patients with multiple sclerosis?
    Poser S; Bauer HJ; Ritter G; Friedrich H; Beland H; Denecke P
    J Neurol; 1981; 224(4):283-90. PubMed ID: 6162930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Course and prognosis in early-onset MS: comparison with adult-onset forms.
    Simone IL; Carrara D; Tortorella C; Liguori M; Lepore V; Pellegrini F; Bellacosa A; Ceccarelli A; Pavone I; Livrea P
    Neurology; 2002 Dec; 59(12):1922-8. PubMed ID: 12499484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors.
    Hawkins SA; McDonnell GV
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):148-52. PubMed ID: 10406979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis and gestation.
    Poser S; Poser W
    Neurology; 1983 Nov; 33(11):1422-7. PubMed ID: 6685234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient reported outcomes in benign multiple sclerosis.
    Hviid LE; Healy BC; Rintell DJ; Chitnis T; Weiner HL; Glanz BI
    Mult Scler; 2011 Jul; 17(7):876-84. PubMed ID: 21372114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic criteria in an epidemiological group of patients with multiple sclerosis: an exploratory study.
    Lauer K; Firnhaber W
    J Neurol; 1992 Feb; 239(2):93-7. PubMed ID: 1552310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of brain atrophy in benign vs early multiple sclerosis.
    Gauthier SA; Berger AM; Liptak Z; Duan Y; Egorova S; Buckle GJ; Glanz BI; Khoury SJ; Bakshi R; Weiner HL; Guttmann CR
    Arch Neurol; 2009 Feb; 66(2):234-7. PubMed ID: 19204160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apo E in multiple sclerosis and optic neuritis: the apo E-epsilon4 allele is associated with progression of multiple sclerosis.
    Pinholt M; Frederiksen JL; Andersen PS; Christiansen M
    Mult Scler; 2005 Oct; 11(5):511-5. PubMed ID: 16193886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Benign forms of multiple sclerosis].
    Edan G; Sabouraud O
    Rev Prat; 1991 Sep; 41(20):1904-7. PubMed ID: 1925374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.